NMVA
PFE icon

New Mountain Vantage Advisers’s Pfizer PFE Stock Holding History

New Mountain Vantage Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-700,957
Closed -$19.7M – 40
2016
Q1 		$19.7M Buy
+700,957
New +$20M 1.06% 30

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

New Mountain Vantage Advisers's PFE Position: Q2 2016 in Review

New Mountain Vantage Advisers sold out of Pfizer (PFE) in Q2 2016, closing a stake of 700,957 shares — an estimated $19.7M sold.

New Mountain Vantage Advisers first reported a position in PFE in Q1 2016 and held it in 1 quarter. The position peaked at $19.7M in Q1 2016. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • New Mountain Vantage Advisers reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • New Mountain Vantage Advisers sold 700,957 Pfizer shares in Q2 2016, an estimated $19.7M.
  • New Mountain Vantage Advisers first reported a position in Pfizer in Q1 2016 and held it in 1 quarter.
  • New Mountain Vantage Advisers's Pfizer position peaked at $19.7M in Q1 2016.
  • 1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on New Mountain Vantage Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.